ERNA
Ernexa·NASDAQ
--
--(--)
--
--(--)
2.21 / 10
Underperform
Ernexa Therapeutics' fundamental score is 2.2/10, indicating poor quality. Key weaknesses include low Profit-MV (0.46, group 1), Cash-MV (-0.067, group 1), Asset-MV (-0.50, group 1), and Revenue-MV (-0.25, group 2). Although Inventory turnover ratio (47.85, group 2) and Net profit / Total profit (%) (100.14, group 2) show some strength, they are offset by other deficits. PB-ROE (8.198, group 3) is high, suggesting overvaluation. Overall, the balance of factors is negative, leading to an Underperform rating.
Analysis Checks(6/10)
Revenue-MV
Value-0.26
Score1/3
Weight15.37%
1M Return5.20%
Value-0.26
Score1/3
Weight15.37%
1M Return5.20%
Gross profit margin (%)
Value36.70
Score1/3
Weight-1.19%
1M Return-0.54%
Value36.70
Score1/3
Weight-1.19%
1M Return-0.54%
PB-ROE
Value8.20
Score0/3
Weight10.50%
1M Return3.56%
Value8.20
Score0/3
Weight10.50%
1M Return3.56%
Fixed assets turnover ratio
Value7979.42
Score3/3
Weight1.96%
1M Return0.86%
Value7979.42
Score3/3
Weight1.96%
1M Return0.86%
Cash-MV
Value-0.07
Score2/3
Weight23.04%
1M Return7.73%
Value-0.07
Score2/3
Weight23.04%
1M Return7.73%
Inventory turnover ratio
Value47.85
Score3/3
Weight13.50%
1M Return5.26%
Value47.85
Score3/3
Weight13.50%
1M Return5.26%
Profit-MV
Value0.46
Score2/3
Weight23.01%
1M Return7.79%
Value0.46
Score2/3
Weight23.01%
1M Return7.79%
Current assets turnover ratio
Value1.78
Score2/3
Weight2.69%
1M Return1.15%
Value1.78
Score2/3
Weight2.69%
1M Return1.15%
Asset-MV
Value-0.50
Score0/3
Weight7.86%
1M Return2.94%
Value-0.50
Score0/3
Weight7.86%
1M Return2.94%
Net profit / Total profit (%)
Value100.14
Score2/3
Weight3.25%
1M Return1.28%
Value100.14
Score2/3
Weight3.25%
1M Return1.28%
Revenue-MV
Value-0.26
Score1/3
Weight15.37%
1M Return5.20%
Value-0.26
Score1/3
Weight15.37%
1M Return5.20%
Inventory turnover ratio
Value47.85
Score3/3
Weight13.50%
1M Return5.26%
Value47.85
Score3/3
Weight13.50%
1M Return5.26%
Gross profit margin (%)
Value36.70
Score1/3
Weight-1.19%
1M Return-0.54%
Value36.70
Score1/3
Weight-1.19%
1M Return-0.54%
Profit-MV
Value0.46
Score2/3
Weight23.01%
1M Return7.79%
Value0.46
Score2/3
Weight23.01%
1M Return7.79%
PB-ROE
Value8.20
Score0/3
Weight10.50%
1M Return3.56%
Value8.20
Score0/3
Weight10.50%
1M Return3.56%
Current assets turnover ratio
Value1.78
Score2/3
Weight2.69%
1M Return1.15%
Value1.78
Score2/3
Weight2.69%
1M Return1.15%
Fixed assets turnover ratio
Value7979.42
Score3/3
Weight1.96%
1M Return0.86%
Value7979.42
Score3/3
Weight1.96%
1M Return0.86%
Asset-MV
Value-0.50
Score0/3
Weight7.86%
1M Return2.94%
Value-0.50
Score0/3
Weight7.86%
1M Return2.94%
Cash-MV
Value-0.07
Score2/3
Weight23.04%
1M Return7.73%
Value-0.07
Score2/3
Weight23.04%
1M Return7.73%
Net profit / Total profit (%)
Value100.14
Score2/3
Weight3.25%
1M Return1.28%
Value100.14
Score2/3
Weight3.25%
1M Return1.28%
Is ERNA fundamentally strong?
- ERNA scores 2.21/10 on fundamentals and holds a Premium valuation at present. Backed by its -477.71% ROE, 0.00% net margin, -0.16 P/E ratio, 0.83 P/B ratio, and 145.22% earnings growth, these metrics solidify its Underperform investment rating.
